How can guidelines contribute to reducing "preventable" mortality in patients with upper gastrointestinal bleeding on antithrombotic drugs?

Dig Endosc. 2022 May;34(4):738-740. doi: 10.1111/den.14268. Epub 2022 Mar 1.

Authors

Koichiro Kawaguchi¹, Hajime Isomoto¹

Affiliation

¹ Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori, Japan.

PMID: 35233834
DOI: 10.1111/den.14268

No abstract available

Publication types

Editorial
Comment

MeSH terms

Fibrinolytic Agents* / adverse effects
Gastrointestinal Hemorrhage* / chemically induced
Humans
Risk Factors

Substances

Fibrinolytic Agents